Randomized Controlled Field Trial to Assess the Immunogenicity and Safety of Rift Valley Fever Clone 13 Vaccine in Livestock

PLoS Neglected Tropical Diseases

Volumn 9, Issue 3, 2015, Pages

  Njenga, M Kariuki ^a,b   Njagi, Leonard ^c   Thumbi, S Mwangi ^b   Kahariri, Samuel ^c   Githinji, Jane ^c   Omondi, Eunice ^c   Baden, Amy ^a   Murithi, Mbabu ^c   Paweska, Janusz ^d   Ithondeka, Peter M ^c   Ngeiywa, Kisa J ^c   Dungu, Baptiste ^e   Donadeu, Meritxell ^e   Munyua, Peninah M ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b WASHINGTON STATE UNIVERSITY   (United States)

^c Ministry of Agriculture and Livestock Development   (Kenya)

^d NATIONAL INSTITUTE FOR COMMUNICABLE DISEASES   (South Africa)

^e Bush Loan   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLONE 13 RIFT VALLEY FEVER VACCINE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PLACEBO; UNCLASSIFIED DRUG; VACCINE; NEUTRALIZING ANTIBODY; VIRUS ANTIBODY; VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG SAFETY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOPATHOLOGY; IMMUNOGENICITY; LIVESTOCK; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; PREGNANCY; RANDOMIZED CONTROLLED TRIAL; RIFT VALLEY FEVER; VACCINATION; VIRUS NEUTRALIZATION; ANIMAL; BLOOD; BOVINE; GOAT; IMMUNOLOGY; KENYA; RIFT VALLEY FEVER VIRUS; SHEEP; SOUTH AFRICA;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; CATTLE; FEMALE; GOATS; KENYA; LIVESTOCK; MALE; RIFT VALLEY FEVER VIRUS; SHEEP; SOUTH AFRICA; VIRAL VACCINES;

EID: 84928810167     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0003550     Document Type: Article

References (37)

1. Bishop DH, Calisher CH, Casals J, Chumakov MP, Gaidamovich SY, et al. (1980) Bunyaviridae. Intervirology 14: 125–143. 6165702
2. Al-Afaleq AI, Abu Elzein EME, Mousa SM, Abbas AM, (2003) A retrospective study of Rift Valley fever in Saudi Arabia. Rev Sci Tech 22: 867–871. 15005544
3. Shoemaker T, Boulianne C, Vincent MJ, Pezzanite L, Al-Qahtani MM, et al. (2002) Genetic analysis of viruses associated with emergence of Rift Valley fever in Saudi Arabia and Yemen, 2000–01. Emerg Infect Dis 8: 1415–1420. 12498657
4. El-Akkad AM, (1978) Rift Valley fever outbreak in Egypt. October—December 1977. J Egypt Public Health Assoc 53: 123–128. 572393
5. Meegan JM, (1979) The Rift Valley fever epizootic in Egypt 1977–78. 1. Description of the epizzotic and virological studies. Trans R Soc Trop Med Hyg 73: 618–623. 538803
6. Saluzzo JF, Digoutte JP, Camicas JL, Chauvancy G, (1985) Crimean-Congo haemorrhagic fever and Rift Valley fever in south-eastern Mauritania. Lancet 1: 116. 2857020
7. Zeller HG, Fontenille D, Traore-Lamizana M, Thiongane Y, Digoutte JP, (1997) Enzootic activity of Rift Valley fever virus in Senegal. Am J Trop Med Hyg 56: 265–272. 9129528
8. Al-Hazmi M, Ayoola EA, Abdurahman M, Banzal S, Ashraf J, et al. (2003) Epidemic Rift Valley fever in Saudi Arabia: a clinical study of severe illness in humans. Clin Infect Dis 36: 245–252. 12539063
9. Nguku PM, Sharif SK, Mutonga D, Amwayi S, Omolo J, et al. (2010) An investigation of a major outbreak of Rift Valley fever in Kenya: 2006–2007. Am J Trop Med Hyg 83: 5–13. doi: 10.4269/ajtmh.2010.09-0288 20682900
10. Mohamed M, Mosha F, Mghamba J, Zaki SR, Shieh W-J, et al. (2010) Epidemiologic and clinical aspects of a Rift Valley fever outbreak in humans in Tanzania, 2007. Am J Trop Med Hyg 83: 22–27. doi: 10.4269/ajtmh.2010.09-0318 20682902
11. Nderitu L, Lee JS, Omolo J, Omulo S, O’Guinn ML, et al. (2011) Sequential Rift Valley fever outbreaks in eastern Africa caused by multiple lineages of the virus. J Infect Dis 203: 655–665. doi: 10.1093/infdis/jiq004 21282193
12. Laughlin LW, Meegan JM, Strausbaugh LJ, Morens DM, Watten RH, (1979) Epidemic Rift Valley fever in Egypt: observations of the spectrum of human illness. Trans R Soc Trop Med Hyg 73: 630–633. 575446
13. Peters C, Mandell GI BJ, Dolin R, Douglas M, Bennett’s (2000) California encephalitis, Hantavirus pulmonary syndrome, and Bunyaviridae hemorrhagic fevers. In: Principles and practice of infectious diseases. New York: Churchill Livingstone. pp. 1845–1855.
14. Swanepoel J, (2004) Rift Valley Fever. nfectious diseases of livestock with special reference to southern Africa. Cape Town: Oxford University Press. pp. 1037–1070.
15. Rich KM, Wanyoike F, (2010) An assessment of the regional and national socio-economic impacts of the 2007 Rift Valley fever outbreak in Kenya. Am J Trop Med Hyg 83: 52–57. doi: 10.4269/ajtmh.2010.09-0291 20682906
16. Anyangu AS, Gould LH, Sharif SK, Nguku PM, Omolo JO, et al. (2010) Risk factors for severe Rift Valley fever infection in Kenya, 2007. Am J Trop Med Hyg 83: 14–21. doi: 10.4269/ajtmh.2010.09-0293 20682901
17. Anyamba A, Chretien J-P, Small J, Tucker CJ, Formenty PB, et al. (2009) Prediction of a Rift Valley fever outbreak. Proc Natl Acad Sci U S A 106: 955–959. doi: 10.1073/pnas.0806490106 19144928
18. Anyamba A, Linthicum KJ, Tucker CJ, (2001) Climate-disease connections: Rift Valley fever in Kenya. Cad Saude Publica 17: S133–S140.
19. House JA, Turell MJ, Mebus CA, (1992) Rift Valley fever: present status and risk to the Western Hemisphere. Ann N Y Acad Sci 653: 233–242. 1626877
20. Cg Tool, (2010) Decision-support tool for prevention and control of Rift Valley fever epizootics in the Greater Horn of Africa. Am J Trop Med Hyg 83: 75–85. doi: 10.4269/ajtmh.2010.83s2a03 20682910
21. Assad G, (1983) The use of veterinary vaccines for prevention and control of Rift Valley fever: memorandum from a WHO/FAO meeting. Bull World Health Organ 61: 261–268. 6602663
22. Barnard BJ, (1979) Rift Valley fever vaccine—antibody and immune response in cattle to a live and an inactivated vaccine. J S Afr Vet Assoc 50: 155–157. 551199
23. Kortekaas J, Zingeser J, de Leeuw P, de La Rocque S, Unger H, et al. (2011) Rift Valley Fever Vaccine Development, Progress and Constraints. Emerg Infect Dis 17: e1. doi: 10.3201/eid1709.110506 21888781
24. Randall R, Gibbs CJ, Aulisio CG, Binn LN, Harrison VR, (1962) The development of a formalin-killed Rift Valley fever virus vaccine for use in man. J Immunol 89: 660–671. 13990748
25. Saluzzo JF, Smith JF, (1990) Use of reassortant viruses to map attenuating and temperature-sensitive mutations of the Rift Valley fever virus MP-12 vaccine. Vaccine 8: 369–375. 2396475
26. Vialat P, Muller R, Vu TH, Prehaud C, Bouloy M, (1997) Mapping of the mutations present in the genome of the Rift Valley fever virus attenuated MP12 strain and their putative role in attenuation. Virus Res 52: 43–50. 9453143
27. Morrill JC, Peters CJ, (2011) Mucosal immunization of rhesus macaques with Rift Valley Fever MP-12 vaccine. J Infect Dis 204: 617–625. doi: 10.1093/infdis/jir354 21791664
28. Morrill JC, Laughlin RC, Lokugamage N, Wu J, Pugh R, et al. (2013) Immunogenicity of a recombinant Rift Valley fever MP-12-NSm deletion vaccine candidate in calves. Vaccine 31: 4988–4994. doi: 10.1016/j.vaccine.2013.08.003 23994375
29. Bird BH, Maartens LH, Campbell S, Erasmus BJ, Erickson BR, et al. (2011) Rift Valley fever virus vaccine lacking the NSs and NSm genes is safe, nonteratogenic, and confers protection from viremia, pyrexia, and abortion following challenge in adult and pregnant sheep. J Virol 85: 12901–12909. doi: 10.1128/JVI.06046-11 21976656
30. Muller R, Saluzzo JF, Lopez N, Dreier T, Turell M, et al. (1995) Characterization of clone 13, a naturally attenuated avirulent isolate of Rift Valley fever virus, which is altered in the small segment. Am J Trop Med Hyg 53: 405–411. 7485695
31. Dungu B, Louw I, Lubisi A, Hunter P, von Teichman BF, et al. (2010) Evaluation of the efficacy and safety of the Rift Valley Fever Clone 13 vaccine in sheep. Vaccine 28: 4581–4587. doi: 10.1016/j.vaccine.2010.04.085 20470792
32. Von Teichman B, Engelbrecht A, Zulu G, Dungu B, Pardini A, et al. (2011) Safety and efficacy of Rift Valley fever Smithburn and Clone 13 vaccines in calves. Vaccine 29: 5771–5777. doi: 10.1016/j.vaccine.2011.05.055 21664400
33. Paweska JT, Mortimer E, Leman PA, Swanepoel R, (2005) An inhibition enzyme-linked immunosorbent assay for the detection of antibody to Rift Valley fever virus in humans, domestic and wild ruminants. J Virol Methods 127: 10–18. 15893560
34. Paweska J.T., Burt F.J., Swanepoel R., (2005). Validation of IgG-sandwich and IgM-capture ELISA for the detection of antibody to Rift Valley fever virus in humans. Journal of Virological Methods, 124, 173–181. 15664066
35. Chongsuvivatwong V, (2008) Analysis of epidemiological data using R and Epicalc. Epidemiology.
36. R Development Core Team (2011) R: A language and environment for statistical computing. R Foundation for Statistical Computing.
37. Barnard B.J., (1979). Rift Valley fever vaccine—antibody and immune response in cattle to a live and inactivated vaccine. J. South Africa Vet Assoc 50, 155–157. 551199